US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Crinetics Pharmaceuticals Inc.

84.69

0.0000

Post-market: 84.710.0167+0.02%19:30 EDT

Volume:2.02M

Turnover:170.83M

Market Cap:8.99B

PE:-16.84

High:84.77

Open:84.70

Low:84.69

Close:84.69

52wk High:84.80

52wk Low:29.63

Shares:106.10M

Float Shares:95.53M

Volume Ratio:0.53

T/O Rate:2.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.0290

EPS(LYR):-4.9500

ROE:-42.45%

ROA:-26.28%

PB:7.54

PE(LYR):-17.11

Loading ...

Overview Company News Filings

Crinetics Pharmaceuticals Q1 EPS USD -1.23

THOMSON REUTERS

Crinetics Pharmaceuticals announces annual shareholder meeting

Crinetics Pharmaceuticals Is Maintained at Market Outperform by Citizens

Crinetics price target raised to $97 from $96 at Citizens

Crinetics’ Palsonify approved by European Commission for acromegaly

EU Commission approves Crinetics’ Palsonify for adult acromegaly treatment

Crinetics Pharmaceuticals Announces the European Commission Approval of Palsonify® (Paltusotine) for the Treatment of Acromegaly in Adults

THOMSON REUTERS

Crinetics FY25 net loss widens to $465.3 million; revenue rises to $7.7 million

Crinetics submits Brazil approval application for Palsonify in acromegaly

Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer

THOMSON REUTERS

ALX Oncology names Jeff Knight chief development and operating officer

Crinetics Chief Development and Operating Officer Jeff Knight resigns, becomes consultant

Crinetics to report first-quarter results after market close, host conference call

Why Crinetics Pharmaceuticals (CRNX) Is Up 10.6% After Brazil PALSONIFY Filing Expands Global Footprint

Simply Wall St.

Crinetics submits Palsonify marketing authorization application to ANVISA

Crinetics submits Brazil ANVISA marketing authorization application for Palsonify in acromegaly; CHMP opinion turns positive in Europe

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

THOMSON REUTERS

Crinetics Chief Development and Operating Officer Jeff Knight to resign effective April 10, 2026

Crinetics Pharmaceuticals Director Vivaldi Coelho Rogerio Disposes of Common Shares

Crinetics Pharmaceuticals Director Stephanie Okey Disposes of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/CRNX/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRNX\",,,,,undefined,":{"symbol":"CRNX","market":"US","secType":"STK","nameCN":"Crinetics Pharmaceuticals Inc.","latestPrice":84.69,"timestamp":1787342400000,"preClose":84.69,"halted":0,"volume":2016688,"hourTrading":{"tag":"盘后","latestPrice":84.7067,"preClose":84.69,"latestTime":"19:30 EDT","volume":7888,"amount":668046.3526,"timestamp":1787355006389,"change":0.0167,"changeRate":0.000197,"amplitude":0.000197},"delay":0,"changeRate":0,"floatShares":95530500,"shares":106095205,"eps":-5.029038,"marketStatus":"Market Closed","change":0,"latestTime":"08-21 16:00:00 EDT","open":84.7,"high":84.765,"low":84.69,"amount":170829962.04108799,"amplitude":0.000886,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.029038,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1531886400000,"exchange":"NASDAQ","adjPreClose":84.69,"preHourTrading":{"tag":"盘前","latestPrice":84.7,"preClose":84.69,"latestTime":"09:29 EDT","volume":3102,"amount":262631.41938,"timestamp":1787318999985,"change":0.01,"changeRate":0.000118,"amplitude":0.020309},"postHourTrading":{"tag":"盘后","latestPrice":84.7067,"preClose":84.69,"latestTime":"19:30 EDT","volume":7888,"amount":668046.3526,"timestamp":1787355006389,"change":0.0167,"changeRate":0.000197,"amplitude":0.000197},"volumeRatio":0.529734580571328,"impliedVol":0.102,"impliedVolPercentile":0.0398},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRNX\",,,,,undefined,":{"symbol":"CRNX","floatShares":95530500,"roa":"-26.28%","roe":"-42.45%","lyrEps":-4.95,"volumeRatio":0.529734580571328,"shares":106095205,"dividePrice":0,"high":84.765,"amplitude":0.000886,"preClose":84.69,"low":84.69,"week52Low":29.63,"pbRate":"7.54","psRate":"213.14","week52High":84.795,"institutionHeld":0,"latestPrice":84.69,"eps":-5.029038,"divideRate":0,"volume":2016688,"delay":0,"ttmEps":-5.029038,"open":84.7,"prevYearClose":46.55,"prevWeekClose":84.7,"prevMonthClose":83.52,"prevQuarterClose":37.42,"fiveDayClose":84.7,"twentyDayClose":83.73,"sixtyDayClose":36.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-03","symbol":"CRNX","fiscalQuarterEnding":"2026/06","expectedEps":-1.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785729600000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2026-05-07","symbol":"CRNX","fiscalQuarterEnding":"2026/03","expectedEps":-1.22,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-1.23},{"market":"US","date":"2026-02-26","symbol":"CRNX","fiscalQuarterEnding":"2025/12","expectedEps":-1.37,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-1.29},{"market":"US","date":"2025-11-06","symbol":"CRNX","fiscalQuarterEnding":"2025/09","expectedEps":-1.27,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-1.38},{"market":"US","date":"2025-08-07","symbol":"CRNX","fiscalQuarterEnding":"2025/06","expectedEps":-1.13,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-1.23}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0714,"buy":0,"hold":0.9286,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.9286,"analysts":14,"updateTime":1785211200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRNX","date":"2026-08-21","current":-16.840199,"percent":0.050521,"low":-21.135071,"twenty":-13.839432,"median":-9.61709,"eighty":-7.433247,"high":-4.749275,"avg":-10.67743,"sd":3.813967,"marketCap":8982664244},"quantilePoints":[{"date":"2021-08-27","current":-9.89733,"twenty":-26.503102,"median":-10.6786,"eighty":-7.987732,"marketCap":880436748},{"date":"2021-09-03","current":-10.425582,"twenty":-26.446253,"median":-10.645321,"eighty":-7.995885,"marketCap":927428462},{"date":"2021-09-10","current":-9.800131,"twenty":-26.264335,"median":-10.629198,"eighty":-7.997042,"marketCap":871790273},{"date":"2021-09-17","current":-9.635317,"twenty":-26.123349,"median":-10.607627,"eighty":-7.99806,"marketCap":857128858},{"date":"2021-09-24","current":-8.874634,"twenty":-26.023294,"median":-10.576486,"eighty":-8.000898,"marketCap":789460791},{"date":"2021-10-01","current":-8.959154,"twenty":-24.761242,"median":-10.553033,"eighty":-8.005527,"marketCap":796979465},{"date":"2021-10-08","current":-8.240731,"twenty":-23.773189,"median":-10.492287,"eighty":-8.011129,"marketCap":733070734},{"date":"2021-10-15","current":-8.236505,"twenty":-23.618977,"median":-10.471142,"eighty":-8.01938,"marketCap":732694800},{"date":"2021-10-22","current":-11.634891,"twenty":-23.506395,"median":-10.46987,"eighty":-8.024509,"marketCap":1035005025},{"date":"2021-10-29","current":-13.215665,"twenty":-23.418832,"median":-10.492287,"eighty":-8.027254,"marketCap":1175625929},{"date":"2021-11-05","current":-13.35881,"twenty":-23.379517,"median":-10.552734,"eighty":-8.031346,"marketCap":1315682448},{"date":"2021-11-12","current":-12.870423,"twenty":-23.279444,"median":-10.563952,"eighty":-8.033556,"marketCap":1267582229},{"date":"2021-11-19","current":-13.052371,"twenty":-23.221008,"median":-10.599438,"eighty":-8.034381,"marketCap":1285501919},{"date":"2021-11-26","current":-11.682973,"twenty":-23.206712,"median":-10.620299,"eighty":-8.038017,"marketCap":1150632678},{"date":"2021-12-03","current":-11.807464,"twenty":-23.15078,"median":-10.659957,"eighty":-8.043427,"marketCap":1162893518},{"date":"2021-12-10","current":-12.587925,"twenty":-23.050707,"median":-10.672503,"eighty":-8.050409,"marketCap":1239759554},{"date":"2021-12-17","current":-11.730854,"twenty":-22.824303,"median":-10.684059,"eighty":-8.067845,"marketCap":1155348386},{"date":"2021-12-23","current":-12.693263,"twenty":-22.587462,"median":-10.69865,"eighty":-8.080293,"marketCap":1250134111},{"date":"2021-12-31","current":-13.603003,"twenty":-22.557248,"median":-10.726653,"eighty":-8.085586,"marketCap":1339732557},{"date":"2022-01-07","current":-12.128267,"twenty":-22.43404,"median":-10.764825,"eighty":-8.109087,"marketCap":1194488760},{"date":"2022-01-14","current":-11.496237,"twenty":-22.309681,"median":-10.795382,"eighty":-8.129763,"marketCap":1132241418},{"date":"2022-01-21","current":-9.083033,"twenty":-22.304875,"median":-10.77043,"eighty":-8.136828,"marketCap":894569750},{"date":"2022-01-28","current":-8.551553,"twenty":-22.278215,"median":-10.733194,"eighty":-8.141763,"marketCap":842225395},{"date":"2022-02-04","current":-8.379182,"twenty":-22.216011,"median":-10.708323,"eighty":-8.141763,"marketCap":825248847},{"date":"2022-02-11","current":-8.872356,"twenty":-22.038282,"median":-10.684059,"eighty":-8.146697,"marketCap":873820636},{"date":"2022-02-18","current":-9.351167,"twenty":-21.949418,"median":-10.672503,"eighty":-8.154662,"marketCap":920977713},{"date":"2022-02-25","current":-9.269769,"twenty":-21.838448,"median":-10.661098,"eighty":-8.157856,"marketCap":912961010},{"date":"2022-03-04","current":-8.781382,"twenty":-21.800821,"median":-10.627712,"eighty":-8.159932,"marketCap":864860792},{"date":"2022-03-11","current":-9.24104,"twenty":-21.625625,"median":-10.599438,"eighty":-8.16125,"marketCap":910131586},{"date":"2022-03-18","current":-9.499598,"twenty":-21.49924,"median":-10.563952,"eighty":-8.174173,"marketCap":935596407},{"date":"2022-03-25","current":-9.078245,"twenty":-21.464221,"median":-10.552734,"eighty":-8.181555,"marketCap":894098179},{"date":"2022-04-01","current":-10.467769,"twenty":-21.240284,"median":-10.492287,"eighty":-8.191551,"marketCap":1126761127},{"date":"2022-04-08","current":-10.228049,"twenty":-21.149642,"median":-10.492287,"eighty":-8.193787,"marketCap":1100957437},{"date":"2022-04-14","current":-12.900888,"twenty":-21.039451,"median":-10.492287,"eighty":-8.198276,"marketCap":1388664524},{"date":"2022-04-22","current":-10.429872,"twenty":-20.971914,"median":-10.499338,"eighty":-8.207466,"marketCap":1122681857},{"date":"2022-04-29","current":-10.095773,"twenty":-20.908472,"median":-10.492287,"eighty":-8.211681,"marketCap":1086719127},{"date":"2022-05-06","current":-8.958011,"twenty":-20.861455,"median":-10.471142,"eighty":-8.221088,"marketCap":964249304},{"date":"2022-05-13","current":-8.404617,"twenty":-20.844139,"median":-10.448821,"eighty":-8.211681,"marketCap":1003233918},{"date":"2022-05-20","current":-9.198013,"twenty":-20.834693,"median":-10.421349,"eighty":-8.221088,"marketCap":1097939200},{"date":"2022-05-27","current":-7.526054,"twenty":-20.831716,"median":-10.403533,"eighty":-8.207466,"marketCap":898362533},{"date":"2022-06-03","current":-8.243248,"twenty":-20.809677,"median":-10.389178,"eighty":-8.193787,"marketCap":983971827},{"date":"2022-06-10","current":-8.332898,"twenty":-20.773299,"median":-10.384759,"eighty":-8.193787,"marketCap":994672989},{"date":"2022-06-17","current":-8.198424,"twenty":-20.744964,"median":-10.354491,"eighty":-8.179448,"marketCap":978621246},{"date":"2022-06-24","current":-8.790109,"twenty":-20.711905,"median":-10.335026,"eighty":-8.184663,"marketCap":1049248914},{"date":"2022-07-01","current":-8.449442,"twenty":-20.691921,"median":-10.323152,"eighty":-8.178395,"marketCap":1008584499},{"date":"2022-07-08","current":-9.466961,"twenty":-20.687549,"median":-10.318167,"eighty":-8.182609,"marketCap":1130042686},{"date":"2022-07-15","current":-9.28318,"twenty":-20.685143,"median":-10.298821,"eighty":-8.192879,"marketCap":1108105304},{"date":"2022-07-22","current":-8.740802,"twenty":-20.685143,"median":-10.266577,"eighty":-8.193787,"marketCap":1043363275},{"date":"2022-07-29","current":-8.61081,"twenty":-20.677272,"median":-10.257738,"eighty":-8.193787,"marketCap":1027846590},{"date":"2022-08-05","current":-9.951067,"twenty":-20.634231,"median":-10.228049,"eighty":-8.193787,"marketCap":1187828959},{"date":"2022-08-12","current":-8.14334,"twenty":-20.634231,"median":-10.193824,"eighty":-8.193787,"marketCap":1104619587},{"date":"2022-08-19","current":-8.456393,"twenty":-20.616458,"median":-10.133986,"eighty":-8.198424,"marketCap":1147084282},{"date":"2022-08-26","current":-7.735182,"twenty":-20.614304,"median":-10.125951,"eighty":-8.198424,"marketCap":1049254226},{"date":"2022-09-02","current":-8.012571,"twenty":-20.509821,"median":-10.090805,"eighty":-8.182609,"marketCap":1086881171},{"date":"2022-09-09","current":-8.333549,"twenty":-20.424511,"median":-10.060994,"eighty":-8.181555,"marketCap":1130420921},{"date":"2022-09-16","current":-8.15919,"twenty":-20.381857,"median":-10.025216,"eighty":-8.181555,"marketCap":1106769699},{"date":"2022-09-23","current":-7.196255,"twenty":-20.365249,"median":-9.993514,"eighty":-8.159083,"marketCap":976150448},{"date":"2022-09-30","current":-7.782734,"twenty":-20.324649,"median":-9.960349,"eighty":-8.146026,"marketCap":1055704559},{"date":"2022-10-07","current":-6.89509,"twenty":-20.250514,"median":-9.951067,"eighty":-8.135062,"marketCap":935298337},{"date":"2022-10-14","current":-6.998121,"twenty":-20.227233,"median":-9.937561,"eighty":-8.077801,"marketCap":949274059},{"date":"2022-10-21","current":-6.871314,"twenty":-20.161474,"median":-9.901345,"eighty":-8.056567,"marketCap":932073170},{"date":"2022-10-28","current":-7.430054,"twenty":-20.136431,"median":-9.880744,"eighty":-8.033672,"marketCap":1007864587},{"date":"2022-11-04","current":-7.0853,"twenty":-20.093453,"median":-9.868469,"eighty":-8.024905,"marketCap":961099670},{"date":"2022-11-11","current":-7.287397,"twenty":-20.00435,"median":-9.846345,"eighty":-8.006574,"marketCap":988513587},{"date":"2022-11-18","current":-6.408191,"twenty":-19.956905,"median":-9.828054,"eighty":-7.995885,"marketCap":959440787},{"date":"2022-11-25","current":-6.501636,"twenty":-19.890477,"median":-9.800131,"eighty":-7.968451,"marketCap":973431510},{"date":"2022-12-02","current":-6.62024,"twenty":-19.846329,"median":-9.76245,"eighty":-7.948042,"marketCap":991188967},{"date":"2022-12-09","current":-5.843925,"twenty":-19.776983,"median":-9.757117,"eighty":-7.918241,"marketCap":874958339},{"date":"2022-12-16","current":-6.055974,"twenty":-19.704409,"median":-9.745879,"eighty":-7.88923,"marketCap":906706520},{"date":"2022-12-23","current":-6.002063,"twenty":-19.680796,"median":-9.737368,"eighty":-7.885151,"marketCap":898634949},{"date":"2022-12-30","current":-6.577111,"twenty":-19.669279,"median":-9.699077,"eighty":-7.866381,"marketCap":984731710},{"date":"2023-01-06","current":-6.365063,"twenty":-19.649891,"median":-9.692629,"eighty":-7.843862,"marketCap":952983529},{"date":"2023-01-13","current":-6.483666,"twenty":-19.609956,"median":-9.650259,"eighty":-7.822756,"marketCap":970740987},{"date":"2023-01-20","current":-7.116219,"twenty":-19.559582,"median":-9.629971,"eighty":-7.807377,"marketCap":1065447424},{"date":"2023-01-27","current":-7.331862,"twenty":-19.535969,"median":-9.615242,"eighty":-7.782734,"marketCap":1097733710},{"date":"2023-02-03","current":-7.159348,"twenty":-19.461225,"median":-9.584859,"eighty":-7.754995,"marketCap":1071904681},{"date":"2023-02-10","current":-7.044338,"twenty":-19.457258,"median":-9.535198,"eighty":-7.732248,"marketCap":1054685329},{"date":"2023-02-17","current":-7.461248,"twenty":-19.457258,"median":-9.520574,"eighty":-7.709298,"marketCap":1117105481},{"date":"2023-02-24","current":-7.03715,"twenty":-19.444664,"median":-9.509544,"eighty":-7.687992,"marketCap":1053609120},{"date":"2023-03-03","current":-6.301284,"twenty":-19.422626,"median":-9.493855,"eighty":-7.646654,"marketCap":1032893853},{"date":"2023-03-10","current":-5.682995,"twenty":-19.399013,"median":-9.477341,"eighty":-7.616055,"marketCap":931545187},{"date":"2023-03-17","current":-5.673129,"twenty":-19.387993,"median":-9.468128,"eighty":-7.587875,"marketCap":929927921},{"date":"2023-03-24","current":-5.094305,"twenty":-19.361231,"median":-9.461001,"eighty":-7.548088,"marketCap":835048318},{"date":"2023-03-31","current":-5.281765,"twenty":-19.178623,"median":-9.446929,"eighty":-7.525158,"marketCap":865776371},{"date":"2023-04-06","current":-5.245589,"twenty":-19.1251,"median":-9.437072,"eighty":-7.512026,"marketCap":859846396},{"date":"2023-04-14","current":-5.433049,"twenty":-19.11408,"median":-9.422988,"eighty":-7.490369,"marketCap":890574449},{"date":"2023-04-21","current":-5.663262,"twenty":-19.049538,"median":-9.407112,"eighty":-7.459101,"marketCap":928310655},{"date":"2023-04-28","current":-6.15649,"twenty":-18.975549,"median":-9.36892,"eighty":-7.442722,"marketCap":1009159597},{"date":"2023-05-05","current":-7.039283,"twenty":-18.915729,"median":-9.363864,"eighty":-7.418061,"marketCap":1153865200},{"date":"2023-05-12","current":-6.810723,"twenty":-18.777198,"median":-9.349113,"eighty":-7.362868,"marketCap":1193824364},{"date":"2023-05-19","current":-6.753032,"twenty":-18.692191,"median":-9.337584,"eighty":-7.342882,"marketCap":1183711916},{"date":"2023-05-26","current":-6.771525,"twenty":-18.671726,"median":-9.323372,"eighty":-7.315764,"marketCap":1186953482},{"date":"2023-06-02","current":-6.734539,"twenty":-18.577274,"median":-9.300892,"eighty":-7.298852,"marketCap":1180470350},{"date":"2023-06-09","current":-6.768443,"twenty":-18.389943,"median":-9.284557,"eighty":-7.290458,"marketCap":1186413221},{"date":"2023-06-16","current":-6.401664,"twenty":-18.297064,"median":-9.264981,"eighty":-7.249516,"marketCap":1122122159},{"date":"2023-06-23","current":-5.729752,"twenty":-18.28447,"median":-9.24418,"eighty":-7.231948,"marketCap":1004345254},{"date":"2023-06-30","current":-5.489343,"twenty":-18.252986,"median":-9.233595,"eighty":-7.214095,"marketCap":962204894},{"date":"2023-07-07","current":-5.665026,"twenty":-18.202612,"median":-9.223038,"eighty":-7.194926,"marketCap":992999773},{"date":"2023-07-14","current":-6.312282,"twenty":-17.975925,"median":-9.21146,"eighty":-7.179788,"marketCap":1106454589},{"date":"2023-07-21","current":-6.164337,"twenty":-17.484771,"median":-9.151748,"eighty":-7.171037,"marketCap":1080522060},{"date":"2023-07-28","current":-5.689683,"twenty":-16.271054,"median":-9.132775,"eighty":-7.152878,"marketCap":997321861},{"date":"2023-08-04","current":-5.917764,"twenty":-14.799165,"median":-9.112846,"eighty":-7.130765,"marketCap":1037301177},{"date":"2023-08-11","current":-4.993133,"twenty":-14.41271,"median":-9.10082,"eighty":-7.101953,"marketCap":918187174},{"date":"2023-08-18","current":-4.820648,"twenty":-13.960254,"median":-9.085951,"eighty":-7.076801,"marketCap":886468975},{"date":"2023-08-25","current":-5.112088,"twenty":-13.776575,"median":-9.068669,"eighty":-7.045057,"marketCap":940061794},{"date":"2023-09-01","current":-5.150748,"twenty":-13.602279,"median":-9.044728,"eighty":-7.007837,"marketCap":947171046},{"date":"2023-09-08","current":-4.805779,"twenty":-13.455529,"median":-8.972798,"eighty":-6.979072,"marketCap":883734648},{"date":"2023-09-15","current":-10.528639,"twenty":-13.21365,"median":-8.968118,"eighty":-6.969506,"marketCap":1936111510},{"date":"2023-09-22","current":-10.489747,"twenty":-13.151006,"median":-8.968118,"eighty":-6.969506,"marketCap":1928959535},{"date":"2023-09-29","current":-10.55088,"twenty":-13.088761,"median":-8.968118,"eighty":-6.969506,"marketCap":1940201329},{"date":"2023-10-06","current":-9.637477,"twenty":-13.001031,"median":-8.968118,"eighty":-6.969506,"marketCap":1772235706},{"date":"2023-10-13","current":-9.515211,"twenty":-12.940021,"median":-8.968118,"eighty":-6.969506,"marketCap":1749752119},{"date":"2023-10-20","current":-10.015065,"twenty":-12.865635,"median":-8.968118,"eighty":-6.969506,"marketCap":1841670314},{"date":"2023-10-27","current":-10.507727,"twenty":-12.672735,"median":-8.958583,"eighty":-6.965401,"marketCap":1932265945},{"date":"2023-11-03","current":-10.500535,"twenty":-12.520569,"median":-8.958583,"eighty":-6.965401,"marketCap":1930943381},{"date":"2023-11-10","current":-8.940153,"twenty":-12.431833,"median":-8.949082,"eighty":-6.965401,"marketCap":1782872169},{"date":"2023-11-17","current":-9.492842,"twenty":-12.384119,"median":-8.949082,"eighty":-6.965401,"marketCap":1893090943},{"date":"2023-11-24","current":-10.715455,"twenty":-12.334984,"median":-8.949082,"eighty":-6.965401,"marketCap":2136908231},{"date":"2023-12-01","current":-10.648463,"twenty":-12.252824,"median":-8.949082,"eighty":-6.965401,"marketCap":2123548380},{"date":"2023-12-08","current":-11.21455,"twenty":-12.225037,"median":-8.958011,"eighty":-6.966388,"marketCap":2236439124},{"date":"2023-12-15","current":-11.686847,"twenty":-12.152639,"median":-8.958011,"eighty":-6.966388,"marketCap":2330626076},{"date":"2023-12-22","current":-11.639952,"twenty":-12.10182,"median":-8.958011,"eighty":-6.966388,"marketCap":2321274180},{"date":"2023-12-29","current":-11.974915,"twenty":-12.077207,"median":-8.949082,"eighty":-6.965401,"marketCap":2388073437},{"date":"2024-01-05","current":-11.646651,"twenty":-12.037531,"median":-8.940153,"eighty":-6.964415,"marketCap":2322610165},{"date":"2024-01-12","current":-12.484058,"twenty":-12.02672,"median":-8.940153,"eighty":-6.964415,"marketCap":2489608308},{"date":"2024-01-19","current":-12.125648,"twenty":-12.016913,"median":-8.938652,"eighty":-6.963428,"marketCap":2418133103},{"date":"2024-01-26","current":-12.477359,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":2488272323},{"date":"2024-02-02","current":-12.46396,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":2485600352},{"date":"2024-02-09","current":-12.880989,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":2568765427},{"date":"2024-02-16","current":-12.366821,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":2466228568},{"date":"2024-02-23","current":-12.299829,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":2452868717},{"date":"2024-03-01","current":-12.747748,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":2734761581},{"date":"2024-03-08","current":-15.438497,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3312005280},{"date":"2024-03-15","current":-13.880117,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":2977687570},{"date":"2024-03-22","current":-16.335746,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3504491233},{"date":"2024-03-28","current":-16.139586,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3462409284},{"date":"2024-04-05","current":-16.946021,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":3635412854},{"date":"2024-04-12","current":-17.447318,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":3742955614},{"date":"2024-04-19","current":-15.623759,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":3351749343},{"date":"2024-04-26","current":-15.522839,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3330099153},{"date":"2024-05-03","current":-17.170925,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3683661347},{"date":"2024-05-10","current":-18.139955,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3891546468},{"date":"2024-05-17","current":-17.385236,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":4093597164},{"date":"2024-05-24","current":-16.286727,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3834937971},{"date":"2024-05-31","current":-14.873402,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3502150839},{"date":"2024-06-07","current":-14.973876,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3525808692},{"date":"2024-06-14","current":-15.181521,"twenty":-12.025825,"median":-8.949082,"eighty":-6.965401,"marketCap":3574701588},{"date":"2024-06-21","current":-15.265248,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":3594416465},{"date":"2024-06-28","current":-15.000669,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":3532117452},{"date":"2024-07-05","current":-14.679154,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":3456412323},{"date":"2024-07-12","current":-17.974679,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":4232389901},{"date":"2024-07-19","current":-17.636419,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":4152741796},{"date":"2024-07-26","current":-18.205768,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":4286802963},{"date":"2024-08-02","current":-16.675224,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":3926415002},{"date":"2024-08-09","current":-14.747801,"twenty":-12.00979,"median":-8.940153,"eighty":-6.964415,"marketCap":3812896460},{"date":"2024-08-16","current":-15.97988,"twenty":-12.036548,"median":-8.940153,"eighty":-6.964415,"marketCap":4131438188},{"date":"2024-08-23","current":-16.453518,"twenty":-12.048412,"median":-8.940153,"eighty":-6.964415,"marketCap":4253892671},{"date":"2024-08-30","current":-16.425657,"twenty":-12.092151,"median":-8.940153,"eighty":-6.964415,"marketCap":4246689466},{"date":"2024-09-06","current":-15.599112,"twenty":-12.125526,"median":-8.940153,"eighty":-6.964415,"marketCap":4032994387},{"date":"2024-09-13","current":-16.654737,"twenty":-12.17296,"median":-8.940153,"eighty":-6.964415,"marketCap":4305915818},{"date":"2024-09-20","current":-16.453518,"twenty":-12.227054,"median":-8.940153,"eighty":-6.964415,"marketCap":4253892671},{"date":"2024-09-27","current":-15.710556,"twenty":-12.272743,"median":-8.940153,"eighty":-6.964415,"marketCap":4061807207},{"date":"2024-10-04","current":-16.450423,"twenty":-12.32899,"median":-8.940153,"eighty":-6.964415,"marketCap":4253092315},{"date":"2024-10-11","current":-18.505811,"twenty":-12.35557,"median":-8.940153,"eighty":-6.964415,"marketCap":4784492315},{"date":"2024-10-18","current":-20.577877,"twenty":-12.404669,"median":-8.940153,"eighty":-6.964415,"marketCap":5320204194},{"date":"2024-10-25","current":-20.184358,"twenty":-12.429918,"median":-8.940153,"eighty":-6.964415,"marketCap":5218463955},{"date":"2024-11-01","current":-19.742085,"twenty":-12.458746,"median":-8.940153,"eighty":-6.964415,"marketCap":5104118730},{"date":"2024-11-08","current":-21.135071,"twenty":-12.490087,"median":-8.940153,"eighty":-6.964415,"marketCap":5464261170},{"date":"2024-11-15","current":-18.259879,"twenty":-12.591928,"median":-8.940153,"eighty":-6.964415,"marketCap":5074602949},{"date":"2024-11-22","current":-18.707032,"twenty":-12.64417,"median":-8.940153,"eighty":-6.964415,"marketCap":5198871369},{"date":"2024-11-29","current":-19.087447,"twenty":-12.683273,"median":-8.940153,"eighty":-6.964415,"marketCap":5304592264},{"date":"2024-12-06","current":-19.64472,"twenty":-12.8235,"median":-8.940153,"eighty":-6.964415,"marketCap":5459464101},{"date":"2024-12-13","current":-17.90616,"twenty":-12.91421,"median":-8.940153,"eighty":-6.964415,"marketCap":4976301064},{"date":"2024-12-20","current":-17.886139,"twenty":-12.966659,"median":-8.940153,"eighty":-6.964415,"marketCap":4970736807},{"date":"2024-12-27","current":-17.30217,"twenty":-12.997756,"median":-8.940153,"eighty":-6.964415,"marketCap":4808445959},{"date":"2025-01-03","current":-17.735975,"twenty":-13.015908,"median":-8.940153,"eighty":-6.964415,"marketCap":4929004875},{"date":"2025-01-10","current":-13.544746,"twenty":-13.001031,"median":-8.938652,"eighty":-6.963428,"marketCap":3764220279},{"date":"2025-01-17","current":-12.463569,"twenty":-12.951811,"median":-8.938652,"eighty":-6.963428,"marketCap":3463750368},{"date":"2025-01-24","current":-12.944092,"twenty":-12.946445,"median":-8.938652,"eighty":-6.963428,"marketCap":3597292551},{"date":"2025-01-31","current":-13.447974,"twenty":-12.982147,"median":-8.938652,"eighty":-6.963428,"marketCap":3737326368},{"date":"2025-02-07","current":-12.340101,"twenty":-13.020412,"median":-8.938652,"eighty":-6.963428,"marketCap":3429437446},{"date":"2025-02-14","current":-11.749458,"twenty":-13.020412,"median":-8.938652,"eighty":-6.963428,"marketCap":3265291846},{"date":"2025-02-21","current":-12.500275,"twenty":-13.002744,"median":-8.938652,"eighty":-6.963428,"marketCap":3473951507},{"date":"2025-02-28","current":-11.156794,"twenty":-13.002744,"median":-8.938652,"eighty":-6.963428,"marketCap":3329276689},{"date":"2025-03-07","current":-10.377253,"twenty":-13.007494,"median":-8.937152,"eighty":-6.962441,"marketCap":3096655344},{"date":"2025-03-14","current":-10.748315,"twenty":-13.007494,"median":-8.968118,"eighty":-6.97803,"marketCap":3207383104},{"date":"2025-03-21","current":-10.732724,"twenty":-13.007494,"median":-9.020788,"eighty":-7.011785,"marketCap":3202730677},{"date":"2025-03-28","current":-10.829387,"twenty":-13.007494,"median":-9.054304,"eighty":-7.03715,"marketCap":3231575724},{"date":"2025-04-04","current":-8.384746,"twenty":-13.007494,"median":-9.072285,"eighty":-7.047932,"marketCap":2502075186},{"date":"2025-04-11","current":-9.076978,"twenty":-13.002744,"median":-9.074632,"eighty":-7.076801,"marketCap":2708642941},{"date":"2025-04-17","current":-9.485458,"twenty":-13.002744,"median":-9.080639,"eighty":-7.080396,"marketCap":2830536525},{"date":"2025-04-25","current":-10.162754,"twenty":-13.007494,"median":-9.078245,"eighty":-7.080278,"marketCap":3032647132},{"date":"2025-05-02","current":-10.592608,"twenty":-13.007494,"median":-9.078245,"eighty":-7.080278,"marketCap":3160919023},{"date":"2025-05-09","current":-8.755792,"twenty":-13.007494,"median":-9.076978,"eighty":-7.080278,"marketCap":2874106388},{"date":"2025-05-16","current":-8.915611,"twenty":-13.007494,"median":-9.054304,"eighty":-7.080278,"marketCap":2926567261},{"date":"2025-05-23","current":-8.59312,"twenty":-13.007494,"median":-9.020788,"eighty":-7.080278,"marketCap":2820708714},{"date":"2025-05-30","current":-8.71013,"twenty":-13.007494,"median":-8.972798,"eighty":-7.080278,"marketCap":2859117567},{"date":"2025-06-06","current":-9.223834,"twenty":-13.007494,"median":-9.020788,"eighty":-7.080278,"marketCap":3027741801},{"date":"2025-06-13","current":-9.181025,"twenty":-13.007494,"median":-9.044799,"eighty":-7.080278,"marketCap":3013689782},{"date":"2025-06-20","current":-8.704422,"twenty":-13.010724,"median":-9.020666,"eighty":-7.079409,"marketCap":2857243965},{"date":"2025-06-27","current":-8.558873,"twenty":-13.010724,"median":-8.968555,"eighty":-7.079409,"marketCap":2809467098},{"date":"2025-07-03","current":-8.504648,"twenty":-13.010724,"median":-8.946433,"eighty":-7.079409,"marketCap":2791667874},{"date":"2025-07-11","current":-9.129655,"twenty":-13.010724,"median":-8.935157,"eighty":-7.079409,"marketCap":2996827358},{"date":"2025-07-18","current":-9.423607,"twenty":-13.010724,"median":-8.968555,"eighty":-7.079409,"marketCap":3093317892},{"date":"2025-07-25","current":-8.678737,"twenty":-13.010724,"median":-8.968555,"eighty":-7.079409,"marketCap":2848812753},{"date":"2025-08-01","current":-8.159326,"twenty":-13.010724,"median":-8.968555,"eighty":-7.079409,"marketCap":2678314916},{"date":"2025-08-08","current":-7.956698,"twenty":-13.010724,"median":-8.968555,"eighty":-7.079409,"marketCap":2611802024},{"date":"2025-08-15","current":-7.560379,"twenty":-13.010724,"median":-8.968555,"eighty":-7.068699,"marketCap":2796085261},{"date":"2025-08-22","current":-7.486532,"twenty":-13.010724,"median":-8.968555,"eighty":-7.068699,"marketCap":2768774223},{"date":"2025-08-29","current":-7.804837,"twenty":-13.010724,"median":-8.968555,"eighty":-7.068699,"marketCap":2886494216},{"date":"2025-09-05","current":-8.721556,"twenty":-13.013953,"median":-8.968992,"eighty":-7.063986,"marketCap":3225527794},{"date":"2025-09-12","current":-8.589141,"twenty":-13.010724,"median":-8.987106,"eighty":-7.068699,"marketCap":3176556277},{"date":"2025-09-19","current":-9.034768,"twenty":-13.010724,"median":-9.001778,"eighty":-7.068699,"marketCap":3341364267},{"date":"2025-09-26","current":-9.139172,"twenty":-13.010724,"median":-9.020666,"eighty":-7.068699,"marketCap":3379976424},{"date":"2025-10-03","current":-10.570271,"twenty":-13.010724,"median":-9.046349,"eighty":-7.068699,"marketCap":3909245510},{"date":"2025-10-10","current":-11.652508,"twenty":-13.010724,"median":-9.06737,"eighty":-7.068699,"marketCap":4309493485},{"date":"2025-10-17","current":-10.773986,"twenty":-13.010724,"median":-9.080639,"eighty":-7.068699,"marketCap":3984586306},{"date":"2025-10-24","current":-10.20613,"twenty":-13.010724,"median":-9.093916,"eighty":-7.068699,"marketCap":3774573839},{"date":"2025-10-31","current":-11.020991,"twenty":-13.010724,"median":-9.102394,"eighty":-7.085701,"marketCap":4075937020},{"date":"2025-11-07","current":-9.680319,"twenty":-13.010724,"median":-9.112689,"eighty":-7.127412,"marketCap":4095713979},{"date":"2025-11-14","current":-9.291886,"twenty":-13.010724,"median":-9.121574,"eighty":-7.158629,"marketCap":3931368931},{"date":"2025-11-21","current":-9.412996,"twenty":-13.010724,"median":-9.137437,"eighty":-7.177318,"marketCap":3982610524},{"date":"2025-11-28","current":-10.218159,"twenty":-13.010724,"median":-9.168122,"eighty":-7.187378,"marketCap":4323272230},{"date":"2025-12-05","current":-10.635318,"twenty":-13.010724,"median":-9.212779,"eighty":-7.213697,"marketCap":4499771052},{"date":"2025-12-12","current":-11.059205,"twenty":-13.010724,"median":-9.224371,"eighty":-7.239267,"marketCap":4679116630},{"date":"2025-12-19","current":-10.123961,"twenty":-13.010724,"median":-9.24418,"eighty":-7.288466,"marketCap":4283417657},{"date":"2025-12-26","current":-10.924638,"twenty":-13.010724,"median":-9.276474,"eighty":-7.301783,"marketCap":4622181526},{"date":"2026-01-02","current":-10.440195,"twenty":-13.010724,"median":-9.293195,"eighty":-7.328026,"marketCap":4417215152},{"date":"2026-01-09","current":-11.940623,"twenty":-13.010724,"median":-9.313329,"eighty":-7.364759,"marketCap":5052041561},{"date":"2026-01-16","current":-13.67238,"twenty":-13.083015,"median":-9.339953,"eighty":-7.429298,"marketCap":5784743131},{"date":"2026-01-23","current":-13.313792,"twenty":-13.120362,"median":-9.360199,"eighty":-7.430978,"marketCap":5633025608},{"date":"2026-01-30","current":-12.569964,"twenty":-13.120362,"median":-9.40419,"eighty":-7.460175,"marketCap":5318314259},{"date":"2026-02-06","current":-10.852134,"twenty":-13.120362,"median":-9.42218,"eighty":-7.486332,"marketCap":4591505313},{"date":"2026-02-13","current":-10.680109,"twenty":-13.120362,"median":-9.440338,"eighty":-7.486332,"marketCap":4518721907},{"date":"2026-02-20","current":-10.660725,"twenty":-13.120362,"median":-9.461001,"eighty":-7.486332,"marketCap":4510520960},{"date":"2026-02-27","current":-9.636157,"twenty":-13.120362,"median":-9.477341,"eighty":-7.492182,"marketCap":4483867881},{"date":"2026-03-06","current":-8.753253,"twenty":-13.120362,"median":-9.477341,"eighty":-7.505334,"marketCap":4073037337},{"date":"2026-03-13","current":-8.215457,"twenty":-13.120362,"median":-9.477341,"eighty":-7.512242,"marketCap":3822791598},{"date":"2026-03-20","current":-8.060193,"twenty":-13.120362,"median":-9.477341,"eighty":-7.512242,"marketCap":3750544920},{"date":"2026-03-27","current":-8.170453,"twenty":-13.120362,"median":-9.477341,"eighty":-7.512242,"marketCap":3801850532},{"date":"2026-04-02","current":-8.228958,"twenty":-13.120362,"median":-9.477341,"eighty":-7.528508,"marketCap":3829073918},{"date":"2026-04-10","current":-8.917517,"twenty":-13.120362,"median":-9.477341,"eighty":-7.545668,"marketCap":4149472227},{"date":"2026-04-17","current":-8.780255,"twenty":-13.120362,"median":-9.477341,"eighty":-7.545668,"marketCap":4085601976},{"date":"2026-04-24","current":-8.665495,"twenty":-13.120362,"median":-9.477341,"eighty":-7.545668,"marketCap":4032202258},{"date":"2026-05-01","current":-8.72625,"twenty":-13.120362,"median":-9.477341,"eighty":-7.545668,"marketCap":4060472697},{"date":"2026-05-08","current":-9.786092,"twenty":-13.120362,"median":-9.482471,"eighty":-7.545668,"marketCap":4553634801},{"date":"2026-05-15","current":-8.137615,"twenty":-13.120362,"median":-9.482471,"eighty":-7.55809,"marketCap":4039414368},{"date":"2026-05-22","current":-7.878469,"twenty":-13.120362,"median":-9.482471,"eighty":-7.528508,"marketCap":3910777314},{"date":"2026-05-29","current":-7.649061,"twenty":-13.12132,"median":-9.485234,"eighty":-7.527895,"marketCap":3796901890},{"date":"2026-06-05","current":-7.355928,"twenty":-13.120362,"median":-9.482471,"eighty":-7.505334,"marketCap":3651394403},{"date":"2026-06-12","current":-7.122272,"twenty":-13.120362,"median":-9.482471,"eighty":-7.477505,"marketCap":3535410174},{"date":"2026-06-18","current":-7.593833,"twenty":-13.120362,"median":-9.482471,"eighty":-7.437135,"marketCap":3769487436},{"date":"2026-06-26","current":-7.432397,"twenty":-13.12132,"median":-9.466961,"eighty":-7.433672,"marketCap":3689352877},{"date":"2026-07-02","current":-8.216208,"twenty":-13.12132,"median":-9.466961,"eighty":-7.433672,"marketCap":4078427245},{"date":"2026-07-10","current":-17.762134,"twenty":-13.158116,"median":-9.456505,"eighty":-7.433672,"marketCap":8816910192},{"date":"2026-07-17","current":-17.823734,"twenty":-13.20962,"median":-9.472744,"eighty":-7.433672,"marketCap":8847487853},{"date":"2026-07-24","current":-17.768506,"twenty":-13.332954,"median":-9.492842,"eighty":-7.433672,"marketCap":8820073399},{"date":"2026-07-31","current":-17.764258,"twenty":-13.426699,"median":-9.510504,"eighty":-7.433247,"marketCap":8817964595},{"date":"2026-08-07","current":-17.744991,"twenty":-13.488389,"median":-9.54101,"eighty":-7.433247,"marketCap":8900994017},{"date":"2026-08-14","current":-17.854946,"twenty":-13.561839,"median":-9.590572,"eighty":-7.433247,"marketCap":8956147936},{"date":"2026-08-21","current":-17.907809,"twenty":-13.839432,"median":-9.61709,"eighty":-7.433247,"marketCap":8982664244}],"updateTime":1787502370621},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRNX\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633376174","title":"Crinetics Pharmaceuticals Q1 EPS USD -1.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2633376174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633376174?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184305,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLX4FD857:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRNX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631852983","title":"Crinetics Pharmaceuticals announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631852983","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631852983?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:24","pubTimestamp":1777494255,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals will hold its annual shareholder meeting in San Diego, California on June 18, 2026.Shareholders will vote to elect three Class II directors to serve terms expiring at 2029 annual meeting.Investors will also cast advisory vote on compensation for named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL7SxQ2s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630802583","title":"Crinetics Pharmaceuticals Is Maintained at Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2630802583","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630802583?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:00","pubTimestamp":1777384800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 28, 2026 10:00 ET (14:00 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRNX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630372401","title":"Crinetics price target raised to $97 from $96 at Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2630372401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630372401?lang=en_us&edition=fundamental","pubTime":"2026-04-28 17:45","pubTimestamp":1777369554,"startTime":"0","endTime":"0","summary":"Citizens analyst Jonathan Wolleben raised the firm’s price target on Crinetics (CRNX) to $97 from $96 and keeps an Outperform rating on the shares....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/crinetics-price-target-raised-to-97-from-96-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/crinetics-price-target-raised-to-97-from-96-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630438913","title":"Crinetics’ Palsonify approved by European Commission for acromegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2630438913","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630438913?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:22","pubTimestamp":1777324952,"startTime":"0","endTime":"0","summary":"Crinetics (CRNX) announced that the European Commission has approved Palsonify – paltusotine -, the first once-daily, oral, selectively-targeted so...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/crinetics-palsonify-approved-by-european-commission-for-acromegaly-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/crinetics-palsonify-approved-by-european-commission-for-acromegaly-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630486713","title":"EU Commission approves Crinetics’ Palsonify for adult acromegaly treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2630486713","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630486713?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:13","pubTimestamp":1777324405,"startTime":"0","endTime":"0","summary":"European Commission cleared Crinetics’ PALSONIFY  for treatment of acromegaly in adults across EU.Decision positions PALSONIFY as first once-daily oral therapy approved for acromegaly in European Union.Crinetics plans initial European launch in Germany and Austria.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL2Hf6CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014021.USD","IE00BN0W2W23.USD","BK4007","CRNX","SG9999014039.USD","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","BK4585","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4139","SG9999014005.SGD","LU0314104364.USD","SG9999014013.SGD","BK4588","BK4112","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630348679","title":"Crinetics Pharmaceuticals Announces the European Commission Approval of Palsonify® (Paltusotine) for the Treatment of Acromegaly in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2630348679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630348679?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:13","pubTimestamp":1777324388,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA9VTCQY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CRNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627833211","title":"Crinetics FY25 net loss widens to $465.3 million; revenue rises to $7.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627833211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627833211?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:23","pubTimestamp":1776349396,"startTime":"0","endTime":"0","summary":"Crinetics posted a net loss of $122.8 million for Q4 2025, widening from $80.6 million a year earlier.Revenue climbed to $6.2 million from no revenue in the prior-year quarter.Research and development expense rose 27.7% to $85.1 million.PALSONIFY generated $5.4 million in net product revenue in Q4, with more than 200 enrollment forms by end-December.Crinetics forecast 2026 GAAP operating expenses of $600 million-$650 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief on April 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL2VmBlL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627021188","title":"Crinetics submits Brazil approval application for Palsonify in acromegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2627021188","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627021188?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:23","pubTimestamp":1776349386,"startTime":"0","endTime":"0","summary":"Crinetics submitted a marketing authorization application to Brazil regulator ANVISA for Palsonify  to treat adult acromegaly.Filing follows FDA approval in US; Europe review advanced with a positive CHMP opinion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief on April 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL9wFVGf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627326234","title":"Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627326234","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627326234?lang=en_us&edition=fundamental","pubTime":"2026-04-16 02:00","pubTimestamp":1776276000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA9Y85RK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CRNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627811453","title":"ALX Oncology names Jeff Knight chief development and operating officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627811453","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627811453?lang=en_us&edition=fundamental","pubTime":"2026-04-13 20:33","pubTimestamp":1776083616,"startTime":"0","endTime":"0","summary":"ALX Oncology appointed Jeff Knight as chief development and operating officer, effective April 13, 2026.Knight most recently served as chief development and operating officer at Crinetics Pharmaceuticals, overseeing clinical development, portfolio strategy, corporate operations.He previously held senior roles at Poseida Therapeutics, Halozyme Therapeutics, Amgen, Onyx Pharmaceuticals, with earlier oncology clinical development, regulatory experience at Genentech.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL2zdCVP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO","BK4533","LU1023059063.AUD","SG9999014039.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4581","IE00BJJMRZ35.SGD","LU0109394709.USD","ALXO","BK4007","BK4585","LU2210150020.SGD","BK4588","IE00BJT1NW94.SGD","LU0320765992.SGD","LU2112291526.USD","LU1983299246.USD","LU1057294990.SGD","BK4112","LU2210149790.SGD","CRNX","LU2242646821.SGD","LU0889565916.HKD","BK4566","LU0053671581.USD","LU0289739699.SGD","NDAQ","LU2089984988.USD","IE0009355771.USD","LU0058720904.USD","LU0868494617.USD","BK4139","BK4534","LU1571399168.USD","LU2468319806.SGD","SG9999014005.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BN0W2T93.GBP","LU0122379950.USD","LU0314104364.USD","LU1061106388.HKD","LU2095319765.USD","SG9999014013.SGD","AMGN","SG9999014021.USD","IE00B3QW5Z07.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626110759","title":"Crinetics Chief Development and Operating Officer Jeff Knight resigns, becomes consultant","url":"https://stock-news.laohu8.com/highlight/detail?id=2626110759","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626110759?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:10","pubTimestamp":1775851843,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Chief Development and Operating Officer Jeff Knight resigned effective April 10, 2026.Knight entered independent consulting agreement covering operational and clinical development services through April 10, 2027.Consulting term includes option for 6-month renewal by mutual written agreement.Unvested restricted stock units and stock options were forfeited on resignation date.Vested stock options remain exercisable until three months after consulting period ends, subject to earlier termination for cause.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval sys","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL1mn3YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626883922","title":"Crinetics to report first-quarter results after market close, host conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2626883922","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626883922?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:07","pubTimestamp":1775678869,"startTime":"0","endTime":"0","summary":"Crinetics schedules Q1 2026 financial results release for May 7, 2026, post-market.Management hosts conference call May 7, 2026 at 4:30 p.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLcdCZbh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2T93.GBP","BK4585","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014013.SGD","NDAQ","SG9999014005.SGD","LU0314104364.USD","BK4007","LU2095319765.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4112","SG9999014021.USD","CRNX","LU2210150020.SGD","BK4588","IE00BN0W2W23.USD","BK4139","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625962459","title":"Why Crinetics Pharmaceuticals (CRNX) Is Up 10.6% After Brazil PALSONIFY Filing Expands Global Footprint","url":"https://stock-news.laohu8.com/highlight/detail?id=2625962459","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625962459?lang=en_us&edition=fundamental","pubTime":"2026-04-06 10:13","pubTimestamp":1775441634,"startTime":"0","endTime":"0","summary":"In March 2026, Crinetics Pharmaceuticals submitted a Marketing Authorization Application to Brazil’s ANVISA for PALSONIFY, an oral somatostatin receptor type 2 agonist for adult acromegaly, supported by 18 clinical trials including two Phase 3 studies that met all primary and secondary endpoints and showed favorable tolerability, biochemical control and symptom relief versus placebo.\nThis filing extends PALSONIFY’s regulatory footprint beyond its existing US approval and recent positive CHMP...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/why-crinetics-pharmaceuticals-crnx-is-up-106-after-brazil-pa","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/why-crinetics-pharmaceuticals-crnx-is-up-106-after-brazil-pa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AIPO","BK4588","BK4587","CHAT","AI","BK4528","CRNX","AIYY","AGIX","BK4139","BK4007","ARTY","BK4551","BK4543","BK4585","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622899268","title":"Crinetics submits Palsonify marketing authorization application to ANVISA","url":"https://stock-news.laohu8.com/highlight/detail?id=2622899268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622899268?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:40","pubTimestamp":1774557614,"startTime":"0","endTime":"0","summary":"Crinetics (CRNX) announced the submission of a marketing authorization application to Brazil’s National Health Surveillance Agency, or ANVISA, for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/crinetics-submits-palsonify-marketing-authorization-application-to-anvisa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/crinetics-submits-palsonify-marketing-authorization-application-to-anvisa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","CRNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622896084","title":"Crinetics submits Brazil ANVISA marketing authorization application for Palsonify in acromegaly; CHMP opinion turns positive in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2622896084","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622896084?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:18","pubTimestamp":1774556282,"startTime":"0","endTime":"0","summary":"Crinetics submits Brazil ANVISA marketing authorization application for Palsonify in acromegaly; CHMP opinion turns positive in Europe. Crinetics submitted a Marketing Authorization Application to Brazil’s ANVISA for Palsonify  to treat acromegaly in adults.The application is supported by data from 18 clinical trials, including two Phase 3 studies in medically untreated and treated patients.Palsonify is approved in the US for adults with acromegaly who had an inadequate response to surgery or for whom surgery is not an option.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief on March 26, 2026, and is solely responsible for the information conta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL9z05gV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622389660","title":"Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2622389660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622389660?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:05","pubTimestamp":1774555521,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621061207","title":"Crinetics Chief Development and Operating Officer Jeff Knight to resign effective April 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621061207","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621061207?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:04","pubTimestamp":1774271084,"startTime":"0","endTime":"0","summary":"Jeff Knight resigned as chief development and operating officer at Crinetics, effective on or about April 10, 2026.The departure was to pursue another opportunity, and it was not related to any disagreement with the company’s operations, policies, or practices.Managerial responsibilities and direct reports will be reassigned to other members of the executive leadership team.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDLbhjLFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619114585","title":"Crinetics Pharmaceuticals Director Vivaldi Coelho Rogerio Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2619114585","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619114585?lang=en_us&edition=fundamental","pubTime":"2026-03-14 05:46","pubTimestamp":1773438401,"startTime":"0","endTime":"0","summary":"Vivaldi Coelho Rogerio, a director of Crinetics Pharmaceuticals, Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 13, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL54nVy0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crinetics Pharmaceuticals Director Vivaldi Coelho Rogerio Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617562043","title":"Crinetics Pharmaceuticals Director Stephanie Okey Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2617562043","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617562043?lang=en_us&edition=fundamental","pubTime":"2026-03-05 06:45","pubTimestamp":1772664321,"startTime":"0","endTime":"0","summary":"Stephanie Okey, a director, reported a disposal of common shares of Crinetics Pharmaceuticals, Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL3nc2zL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crinetics Pharmaceuticals Director Stephanie Okey Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":132,"code":"91000000","status":"200"}]}}